The MTA1 gene is a recently identified novel candidate breast cancer metastasis-associated gene which has been implicated in the signal transduction or regulation of gene expression. We examined the mRNA expression levels of the MTA1, the human homologue of the rat mta1 gene in 47 surgically resected oesophageal squamous cell carcinomas by quantitative reverse transcription polymerase chain reaction. The relative overexpression of MTA1 mRNA (tumour/normal ratio ≥ 2) was observed in 16 out of 47 (34.0%) oesophageal carcinomas. Oesophageal tumours overexpressing MTA1 mRNA (T/N ratio ≥ 2) showed significantly higher frequencies of adventitial invasion (P < 0.05) and lymph node metastasis (P < 0.05), and tended to have a higher rate of lymphatic involvement than the remaining tumours. Thus, the data suggest that the MTA1 gene might play an important role in invasion and metastasis of oesophageal carcinomas.
Of all malignant neoplasms, human oesophageal carcinoma is among the tumours with the poorest prognosis (Sugimachi et al, 1988) . Similar to other malignant tumours, this undesirable prognosis in the patients with oesophageal carcinomas has been attributed to invasion and metastasis (Sugimachi et al, 1988) . In oesophageal carcinomas, lymph node metastasis and invasion to the neighbouring organs such as the aorta, trachea and bronchus, pericardium and lungs are the most important event in the failure of the treatment of oesophageal carcinomas. Therefore, it is a major goal to identify the molecular mechanisms of invasion and metastasis of the oesophageal carcinomas. Although molecular studies on human oesophageal carcinogenesis have revealed frequent genetic abnormalities including c-myc amplification (Lu et al, 1988) , epidermal growth factor receptor amplification (Lu et al, 1988) , p53 mutations (Hollstein et al, 1990 ) and cyclin D1 overexpression (Nakagawa et al, 1995) , very little is known about the role of these alterations in the mechanisms of invasion and metastasis of this type of cancer.
Metastasis is a complex series of events that involves several gene products, including those important in the detachment of neoplastic cells from the primary tumour, penetration into the blood and lymphatics, arrest at distant sites by adhesion to endothelial cells and underlying matrix, extravasation, the induction of angiogenesis, evasion of host anti-tumour responses, and the growth at metastatic sites (Nicolson, 1988; Liotta et al, 1991) . To identify the genes involved in cancer metastasis, we previously performed differential cDNA library screening using the 13762NF rat mammary adenocarcinoma metastatic system (Pencil et al, 1993 ) and we found a novel candidate metastasis-associated gene mta1 (Toh et al, 1994 (Toh et al, , 1995 . Using the same or a similar method, several metastasis-associated genes have thus been isolated, including nm23, mts-1, WDNM1, WDNM2, elongation factor 1α, stromelysin 3 and pGM21 (Dear et al, 1988 (Dear et al, , 1989 Steeg et al, 1988; Ebralidze et al, 1989; Basset et al, 1990; Phillips et al, 1990; Taniguchi et al, 1992) . With the exception of a few of these genes, such as nm23 and stromelysin 3 (Steeg et al, 1988; Basset et al, 1990) , however, few studies have examined the relationship between the expression of the genes in human carcinoma tissues and their clinicopathological features.
Our previous study showed that the mRNA expression level of mta1 gene was fourfold higher in the highly metastatic mammary adenocarcinoma cell line MTLn3 than in the non-metastatic line MTC.4. The mRNA expression levels of the human homologue of this gene also correlated with metastatic potential in several human breast cancer metastatic systems. The mta1 gene encodes a protein of the molecular mass of ~80 kDa and the correlation observed at mRNA level was also confirmed at the protein level. Although the function of mta1 or its human counterpart MTA1 gene product remains unknown, the deduced amino acid sequence suggests that the mta1/MTA1 protein might be involved in a signal transduction pathway or regulation of gene expression (Toh et al, 1994 (Toh et al, , 1995 . To determine whether the mta1/MTA1 gene plays a role in cancers other than those of the breast, we recently examined the expression of the MTA1 gene in surgically resected specimens of colorectal and gastric carcinomas and their corresponding normal mucosa tissues, and we found that overexpression of the MTA1 gene was related to degree of invasion and lymphatic metastasis in these carcinomas (Toh et al, 1997) . We have now extended our research to oesophageal carcinomas and have found a correlation between MTA1 gene overexpression and tumour invasiveness.
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Overexpression of metastasis-associated MTA1 mRNA in invasive oesophageal carcinomas MATERIALS AND METHODS
Surgical specimens and isolation of total cellular RNA
Oesophageal carcinomas and paired normal mucosa were resected and snap-frozen in liquid nitrogen, immediately after surgical resection. The carcinoma tissue samples were obtained from a portion of the resected specimens after excluding necrotic or ulcerated parts and normal adjacent tissues. Specimens were stored at -80°C until the total RNA was extracted. Forty-seven oesophageal carcinomas along with their corresponding normal mucosa were obtained at Kyushu University Hospital and its facilitated hospitals in Japan during the 2-year period from 1995 to 1997.
Total cellular RNA was isolated from carcinomas and normal epithelia according to the method described by Chomzynski and Sacchi (1987) using Isogen (Nippon Gene, Tokyo, Japan) containing phenol and guanidine isothionate in a monophasic solution.
cDNA synthesis by reverse transcription (RT) and quantitative RT-polymerase chain reaction (RT-PCR)
The methods for cDNA synthesis and optimization of quantitative RT-PCR for clinical samples were described in detail in our previous paper (Toh et al, 1997) . The relative amounts of MTA1 expression were normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) expression, and the MTA1 expression in the carcinoma tissue (T) was compared with that in the corresponding normal mucosa (N). The tumour/normal ratio of MTA1 expression (T/N ratio) in each case was calculated. To minimize variation, each PCR was performed in triplicate and the average expression of MTA1 was compared between the carcinoma and the normal mucosa.
Statistical analysis
All data regarding the clinical and histopathological variables were stored in a Macintosh computer. The Stat View program (Abacus Concepts, Berkeley, CA, USA) was used for all statistical analyses, using the chi-squared test and Fisher's exact probability test. A P-value less than 0.05 was judged to be statistically significant.
RESULTS
To quantitate the relative levels of MTA1 gene expression by RT-PCR and to compare the expression in paired carcinoma and normal epithelium samples, we previously determined the optimal conditions for proportional production of PCR product with amount of RNA template and the number of PCR cycles (Toh et al, 1997) . Briefly, the result for MTA1 indicates a linear relationship between the amount of PCR product and the number of PCR cycles between 30 and 34. Additional cycles reduced the linearity of the amplification response, whereas with fewer cycles the sensitivity of the PCR method decreased. This linear response was observed with three different starting amounts (0.5, 1.0 and 2.0 µg) of total RNA. Therefore, in this study, 32 cycles of amplification and 1.0 µg of total RNA were used for the RT-PCR analysis of MTA1 gene expression. Similar experiments were performed for the RT-PCR of GAPDH mRNA, and the optimal conditions were determined to be 25 cycles of amplification and 1.0 µg of total RNA.
Having confirmed the reproducibility of our quantitative RT-PCR assay for MTA1 gene expression, we analysed the relative expression of MTA1 mRNA in the 47 surgically resected oesophageal carcinomas and compared them with the corresponding normal mucosa tissues. All of the normal oesophageal mucosa expressed MTA1 mRNA in relatively low amounts. Using densitometric analysis of the PCR products, we estimated overexpression (T/N ratio ≥ 2) of the MTA1 mRNA compared with the normal mucosa in 16 out of 47 cases (34.0%), whereas, in the remaining 31 cases, the expression of MTA1 mRNA was similar in the carcinoma and normal mucosa tissues. The representative cases that overexpressed MTA1 mRNA are shown in Figure 1 . The relationship between expression of the MTA1 gene and clinicopathological data of the oesophageal carcinomas was examined. In the oesophageal carcinoma cases, we arbitrarily divided the samples into two groups depending on the level of expression of the MTA1 gene in the tumour samples (T/N ratio ≥ 2 and T/N ratio < 2) ( Table 1 ). Clinicopathological studies demonstrated that 12 out of 16 oesophageal carcinomas overexpressing this gene (T/N ratio ≥ 2) invaded into the adventitia or the neighbouring structures, whereas 13 out of 31 remaining tumours (T/N ratio < 2) were restricted in the proper muscle layer (P < 0.05). Furthermore, MTA1-overexpressing tumours had a significantly higher rate of lymph node metastasis (P < 0.05) and tended to have a higher rate of lymphatic involvement (P = 0.081). No statistically significant differences were observed in age, sex, location of the main tumour, histological differentiation, stage and vascular involvement.
DISCUSSION
About 85% of patients with oesophageal carcinomas are in an advanced stage of the disease at the time of the operation (Sugimachi et al, 1994) , and approximately 40% of these patients have either local tumour invasion into the neighbouring structures or lymph node metastases that preclude complete removal of the cancers (Sugimachi et al, 1994) . Furthermore, the histological findings of lymph node metastasis and the presence of vascular or lymphatic invasion by cancer cells have been widely accepted as unfavourable prognostic factors (Sugimachi et al, 1988) . Therefore, to improve the outcome of the treatment of this disease, it may be necessary not only to diagnose this disease at an early stage but also to understand the molecular mechanisms of invasion and metastasis of oesophageal carcinomas.
Here, we showed that MTA1 gene could be another candidate factor that is associated with invasion and metastasis of oesophageal carcinomas. Previously, we found that MTA1 mRNA was also overexpressed in other tumour tissues in comparison to the normal mucosal tissues (T/N ratio ≥ 2), e.g. in 38.9% of colorectal carcinomas and 38.2% of gastric carcinomas. The colorectal and gastric carcinoma tumours that overexpressed MTA1 mRNA also showed deeper invasion and higher rates of lymph node metastasis (Toh et al, 1997) . That overexpression of the MTA1 mRNA was significantly correlated with tumour invasiveness in three independent carcinoma types strongly suggests the possibility that MTA1 is one of the key molecules associated with tumour invasion and metastasis.
Although the exact function of the mta1/MTA1 gene product is still unknown, its deduced amino acid sequence suggests that this protein is involved in a signal transduction pathway (Toh et al, 1994; . The protein motifs of the MTA1 gene product suggested that there are potential phosphorylation sites for tyrosine kinases, protein kinase C and casein kinase II. In addition, a proline-rich amino acid sequence (LPLRPPPPAP) exists at the carboxy-terminal extremity that completely matches the consensus sequence for a src homology 3 domain (SH3)-binding site (Ren et al, 1993; Yu et al, 1994) . SH3 domains are considered important in protein-protein interactions in signal transduction pathways (Pawson and Gish, 1992) , and they are often associated with cytoskeletal components (Bar-Sagi et al, 1993) as well as being involved in other protein-protein interactions (Seidel-Dugan et al, 1992) .
Recently, Paterno et al (1997) reported a novel, developmentally regulated, immediate early gene named er 1 which is activated by fibroblast growth factor in Xenopus embryos. The predicted ER1 amino acid sequence (accession number AF015454) contains three regions of similarity to mta1/MTA1 gene product which are in turn similar to the MTA1-like sequence found in a C.e legans protein (accession number U41264). The er 1 gene has been shown to be a potent transcription factor and it also contains a SH3-binding domain. Although the er 1 gene does not seem to be a Xenopus homologue of the rat mta 1 gene, the data suggest that they are related members of a gene family with the same or similar functions. Indeed, the amino acid sequence of mta1/MTA1 contains a Zinc-finger motif which is important in some transcription factors. Therefore, it may be possible that mta1/MTA1 protein regulates the expression of a set of proteins which are associated with invasion and metastasis of oesophageal carcinoma cells. For example, Shima et al (1992) reported that matrix metalloproteinase 2 (72 kDa type IV collagenase) and stromelysin were expressed in a portion of the oesophageal carcinomas and they found a good correlation between expression of the matrix metalloproteinase and lymph node metastasis and vascular invasion. Using immunohistochemistry, Kadowaki et al (1994) examined the expressions of E-cadherin and α-catenin in oesophageal squamous cell carcinomas. They found that the reduction of α-catenin and E-cadherin expression was significantly associated with increased invasiveness and lymph node metastasis. Thus, it is of interest to investigate the relationship between the expression of metastasisassociated proteins described above and that of mta1/MTA1 gene product in oesophageal carcinomas. For this purpose, immunohistochemical co-localization of these proteins in resected oesophageal specimens and artificial overexpression mta1/ MTA1 gene in oesophageal carcinoma cell lines followed by in vitro assays for invasion, motility and adhesion will be required.
In conclusion, our studies have shown that the expression of the MTA1 gene is closely related to the invasiveness of oesophageal carcinomas as well as gastric and colorectal carcinomas. The novel MTA1 gene could thus potentially provide new information on the mechanism of invasion and metastasis of the gastrointestinal cancers. To elucidate the association of this gene with invasion and metastasis, transfection studies using sense and antisense mta1/MTA1 cDNA expression plasmids will be necessary. In addition, it is also important to examine MTA1 mRNA expression in various other human cancers, and future studies should therefore include breast, lung and other cancer specimens. Such studies are presently in progress in our laboratories.
